Meet Datwyler at
PDA Week

Datwyler introduces the first-to-market 20ml universal NeoFlex™ plunger, engineered to support the growing demand for large-volume injectable therapies. Designed for compatibility across multiple prefilled syringe and cartridge platforms, this innovation helps simplify development, reduce qualification complexity, and support the next generation of biologic and high-dose therapies.  

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler’s NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products. 

Join Datwyler's Global Biologics Product Expert, Yitian Xiao, for an in-depth poster presentation exploring the evolving landscape of large-volume subcutaneous drug delivery. As biologics and other sensitive therapeutics redefine how patients self-administer at home, the demand for purpose-built container closure systems has never been greater. This session covers the clinical drivers behind high-volume delivery, the performance advantages of the NeoFlex™ plunger platform, and how integrated development partnerships can accelerate timelines for pharmaceutical manufacturers.